Cabaletta Bio, Inc.
CABANasdaqCIK 1759138HealthcareFiscal year ends Dec 31
Reports and events: 140 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-03-2107:24 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-034422 |
| 2024-03-2107:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-073294 |
| 2024-03-2007:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-072048 |
| 2024-02-0116:36 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-021894 |
| 2024-01-0807:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-003872 |
| 2023-11-0907:24 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061528 |
| 2023-11-0907:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-274053 |
| 2023-11-0607:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-270840 |
| 2023-10-0207:38 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-248186 |
| 2023-09-0508:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-228144 |
| 2023-08-2208:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-217481 |
| 2023-08-1007:50 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-040966 |
| 2023-08-1007:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-208095 |
| 2023-07-2408:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-191895 |
| 2023-06-0116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-158936 |
| 2023-05-2216:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-150530 |
| 2023-05-1816:33 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-148212 |
| 2023-05-1616:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-146067 |
| 2023-05-1607:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-145622 |
| 2023-05-1107:38 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-020849 |
| 2023-05-1107:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-141371 |
| 2023-05-0216:39 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-132565 |
| 2023-05-0107:17 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-128724 |
| 2023-04-2107:00 ET | DEF 14A | Proxy statementPeriod 2023-06-01 | 0001193125-23-109203 |
| 2023-03-3107:14 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-086713 |
| 2023-03-1607:24 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-008298 |
| 2023-03-1607:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-071942 |
| 2023-03-0607:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-060668 |
| 2023-01-0907:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-004113 |
| 2022-12-1216:53 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-302822 |
| 2022-12-0816:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-301060 |
| 2022-11-1007:41 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-024168 |
| 2022-11-1007:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-281920 |
| 2022-10-1107:13 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-260195 |
| 2022-09-1206:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-242340 |
| 2022-08-2914:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-232575 |
| 2022-08-1107:41 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016650 |
| 2022-08-1107:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-217960 |
| 2022-08-0317:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-22-085691 |
| 2022-06-0208:00 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-165785 |
| 2022-05-1807:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-153543 |
| 2022-05-1207:45 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001564590-22-019677 |
| 2022-05-1207:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-148046 |
| 2022-05-0216:38 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-136873 |
| 2022-04-2108:00 ET | DEF 14A | Proxy statementPeriod 2022-06-01 | 0001193125-22-112140 |
| 2022-03-1708:24 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001564590-22-010726 |
| 2022-03-1707:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-077793 |
| 2022-03-1408:00 ET | 8-K/A | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-074084 |
| 2022-03-0308:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-063683 |
| 2022-03-0108:05 ET | 8-K | 8.01 Other events | 0001193125-22-059886 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:57 ET. Listed shows no prices and gives no investment advice.